1.
Journal of Experimental Hematology
;
(6): 988-992, 2021.
Article
in Chinese
| WPRIM
| ID: wpr-880180
ABSTRACT
Novel coronavirus disease 2019 (COVID-19) has started to erupt in Wuhan since December 2019, and then the cases of COVID-19 increased rapidly, the epidemic situation spreaded to most area of China. Owing to the lack of specific drugs at present, convalescent plasma therapy becomes an alternative treatment. However, the choice of the donor, suitable patients, timing of treatment, administrate dose, the advantages and disadvantages of the treatment are not clear. This article reviews the clinical studies and case reports of convalescent plasma therapy in several previous viral infectious diseases in order to provide clues for the treatment of COVID-19.
Subject(s)
Humans , Blood Component Transfusion , COVID-19/therapy , China , Communicable Diseases , Immunization, Passive , Plasma , SARS-CoV-2
2.
Journal of Applied Clinical Pediatrics
;
(24)2004.
Article
in Chinese
| WPRIM
| ID: wpr-639985
ABSTRACT
0.05).IL-4 in group S0 was significant higher than that in group C(t=11.65 P